Prashanth Gopalakrishna
Impact in
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Papers in
- Genetics 20
- Myeloproliferative Neoplasms: Diagnosis and Treatment 18
- Hematology 14
- Chronic Myeloid Leukemia Treatments 14
- Multiple Myeloma Research and Treatments 2
- Co-authors
- Claire Harrison (11 shared papers)Alessandro M. Vannucchi (12 shared papers)Jean‐Jacques Kiladjian (9 shared papers)Francisco Cervantes (5 shared papers)Vikas Gupta (5 shared papers)Ruben A. Mesa (3 shared papers)Ahmad Naim (2 shared papers)Jason Gotlib (3 shared papers)
- Journals
- Blood (14 papers)Journal of Clinical Oncology (6 papers)Clinical Cancer Research (1 paper)Journal of Hematology & Oncology (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
Prashanth Gopalakrishna
28 papers receiving 620 citations
Peers
Comparison fields: 5 of 36
- Genetics 441
- Hematology 359
- Rheumatology 162
- Oncology 114
- Molecular Biology 241
Countries citing papers authored by Prashanth Gopalakrishna
This map shows the geographic impact of Prashanth Gopalakrishna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prashanth Gopalakrishna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prashanth Gopalakrishna more than expected).
Fields of papers citing papers by Prashanth Gopalakrishna
This network shows the impact of papers produced by Prashanth Gopalakrishna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prashanth Gopalakrishna. The network helps show where Prashanth Gopalakrishna may publish in the future.
Co-authors
The 25 scholars most cited alongside Prashanth Gopalakrishna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 201 | |
| 2 | 2018 | 108 | |
| 3 | 2018 | 54 | |
| 4 | 2013 | 50 | |
| 5 | 2015 | 35 | |
| 6 | 2015 | 32 | |
| 7 | 2015 | 29 | |
| 8 | 2015 | 18 | |
| 9 | 2014 | 12 | |
| 10 | 2015 | 11 | |
| 11 | 2015 | 10 | |
| 12 | 2016 | 10 | |
| 13 | 2015 | 7 | |
| 14 | 2016 | 7 | |
| 15 | 2012 | 7 | |
| 16 | 2014 | 6 | |
| 17 | 2014 | 5 | |
| 18 | 2014 | 5 | |
| 19 | 2013 | 5 | |
| 20 | 2014 | 4 |
About Prashanth Gopalakrishna
Prashanth Gopalakrishna is a scholar working on Genetics, Hematology, Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 28 papers that have together received 631 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers), Chronic Myeloid Leukemia Treatments (14 papers), Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (4 papers), Eosinophilic Disorders and Syndromes (3 papers), Multiple Myeloma Research and Treatments (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and Chemotherapy-related skin toxicity (2 papers). The work is most often cited by research in Genetics (441 citations), Hematology (359 citations), Rheumatology (162 citations), Oncology (114 citations) and Molecular Biology (241 citations). Prashanth Gopalakrishna has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Claire Harrison, Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Francisco Cervantes, Vikas Gupta, Ruben A. Mesa, Ahmad Naim, Jason Gotlib, William Sun and Srđan Verstovšek. Their work appears in journals such as Blood, Journal of Clinical Oncology, Clinical Cancer Research, Journal of Hematology & Oncology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.